Navigation Links
LSTM to lead EU project to coordinate antimalarial drug research

The European Commission is funding a two year, 500,000 project to co-ordinate European and international research into the development of new drugs to treat malaria.

The CRIMALDDI project (Coordination, Rationalisation and Integration of Antimalarial Drug Discovery and Development Initiatives) is being led by the Liverpool School of Tropical Medicine (LSTM) and brings together key players in the antimalarial drug discovery fields including the World Health Organisation, the Medicines for Malaria Venture (MMV) and leading research organisations across Europe.

Professor Steve Ward, Deputy Director of LSTM and Scientific Coordinator of the CRIMALDDI project explained: "New drugs to prevent, treat and eventually eliminate malaria are desperately needed if we are to make an impact upon the millions needlessly dying from this disease each year. Antimalarial drug research and development (R&D) programmes are in operation across Europe and throughout the world, but too often these initiatives are uncoordinated and time and money is spent going over old ground."

CRIMALDDI will address this by assessing research in Europe and internationally. It will develop a prioritised roadmap for antimalarial drug discovery efforts in Europe and a 5-year action plan to deliver on this roadmap. An expert advisory group will provide external validation and ensure that the plans are practical and appropriate. CRIMALDDI will also seek to formulate strategies to ensure better co-ordination of R&D, remove barriers to drug development and facilitate the dissemination of results.

Tim Wells, CSO for MMV said "CRIMALDDI is a timely initiative. It makes a great deal of sense to coordinate efforts globally so that researchers know exactly what is going on in this field and do not run the risk of duplicating efforts. With limited resources available for antimalarial drug R&D, time, funding and expertise are too precious to waste."

Commenting on the project, Professor Ward said: "Co-ordinating research will mean that resources are better directed towards the faster development of new drugs to treat and eliminate malaria. We will look at the global status of antimalarial drug discovery and use that information to ensure that the research agenda for antimalarials in Europe over the next decade is properly aligned with what's going on elsewhere in the world."


Contact: Alan Hughes
Liverpool School of Tropical Medicine

Related medicine news :

1. QI projects may -- or may not -- improve patient safety and outcomes
2. MU researchers to collaborate on $20 million project
3. Fry Construction Selected for High-Profile Medical Imaging Project
4. Jacobs Receives Contract for New Hospital Project in Belgium
5. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
6. Global Health Project targets reducing AIDS among Indias adolescents
7. Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in San Antonio
8. New Business Development of Multi-Hospital Project!
9. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
10. Meth Project Advertisements Selected for National Prevention Campaign
11. Pillow, PAs Great American Sleep Better(TM)Project Reports Results
Post Your Comments:
(Date:11/26/2015)... ... 26, 2015 , ... Jobs in hospital medical laboratories and in the imaging ... staffing agency Aureus Medical Group . These fields, as well as ... searching for healthcare jobs through the company’s website, , The leading ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... has collaborated with Women’s Web – an online resource for Indian women ... mental and emotional well-being relationship, life balance, stress, professional development, and lifestyle. ...
(Date:11/25/2015)... ... November 25, 2015 , ... The holiday season ... and pleasing the palates of attendees is of the utmost importance. Whether you ... seasonal get-together, give these recipes a try this holiday season. , Turkey Croquettes ...
(Date:11/25/2015)... Vegas, NV (PRWEB) , ... November 25, 2015 , ... ... invites patients to learn more about hair loss treatment with the Capillus272™ Pro laser ... an effective solution for thicker and fuller hair, without the need for surgery, prescription ...
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... According ... Vinci surgical robot is being more and more widely heralded as a breakthrough for ... da Vinci method has over traditional laparoscopic surgery is that it can greatly reduce ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Israel , November 25, 2015 ... KTOV ) (TASE: KTOV), a biopharmaceutical company focused ... treatment of various clinical conditions, today announced the closing ... American Depository Shares ( ADSs ), each representing 20 ... up to 3,158,900 ADSs. The ADSs and warrants were ...
(Date:11/25/2015)... , Nov. 25, 2015  Trovagene, Inc. (NASDAQ: ... today announced that Chief Executive Officer Antonius Schuh, Ph.D., ... 27 th Annual Piper Jaffray Healthcare Conference. ... the New York Palace Hotel in New ... 1:30 p.m. EST. Mr. Schuh will be available for ...
(Date:11/25/2015)... Nov. 25, 2015 Allergan plc (NYSE: ... and Rugen Therapeutics, a start-up  biotechnology company focused ... CNS disorders and funded by the F-Prime Biomedical ... entered into an exclusive collaboration to support the ... Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
Breaking Medicine Technology: